Skip to main content
. 2020 Feb 29;106(10):758–764. doi: 10.1136/heartjnl-2019-316075

Table 2.

Table 1 Clinical features according to treatment strategy

Variable OMT
(n=52)
PCI
(n=52)
NYHA Class
 1 31 (59.6%) 39 (75%)
 2 13 (25%) 9 (17.3%)
 3 4 (7.6%) 2 (3.8%)
 4 3 (5.7%) 2 (3.8%)
CCS Class*
 1 11 (21.2%) 14 (26.9%)
 2 30 (57.7%) 30 (57.7%)
 3 4 (7.7%) 4 (7.7%)
 4 7 (13.5%) 4 (7.7%)
Previous PCI 28 (53.8%) 36 (69.2%)
Previous MI 21 (40.4%) 31 (59.6%)
Presentation
Stable angina 32 (61.5%) 21 (40.4%)
Non-culprit NSTEMI 12 (23.1%) 17 (32.7%)
Unstable angina 3 (5.8%) 3 (5.8%)
Non-culprit STEMI 5 (9.6%) 11 (21.2%)

CCS Class may not be indicative of anginal class as per Seattle Angina Questionnaire in the setting of non-culprit disease where scores were calculated at a minimum of 4 weeks post initial PCI in order to ensure scores were reflective of angina from the GZFFR vessel under study.

CCS, Canadian Cardiovascular Society; NSTEMI, non-ST elevation myocardial infarction; OMT, optimal medical therapy group; PCI, percutaneous coronary intervention; STEMI, ST elevation myocardial infarction.